Teva Pharmaceutical Industries income from continuous operations for the twelve months ending December 31, 2024 was $-1.959B, a 218.54% increase year-over-year.
Teva Pharmaceutical Industries annual income from continuous operations for 2024 was $-1.959B, a 218.54% increase from 2023.
Teva Pharmaceutical Industries annual income from continuous operations for 2023 was $-0.615B, a 75.39% decline from 2022.
Teva Pharmaceutical Industries annual income from continuous operations for 2022 was $-2.499B, a 648.03% decline from 2021.
Teva Pharmaceutical Industries Income from Continuous Operations 2010-2024 | TEVA